Michael Grey compensation by year
SPRUCE BIOSCIENCES Summary Compensation Table · all 2 fiscal years held| Component | FY2020 | FY2021 |
|---|---|---|
| Salary | $0 | $65,000 |
| Bonus | $0 | $0 |
| Stock awards | $0 | $0 |
| Option awards | $608,036 | $667,303 |
| Non-equity incentive | $0 | $0 |
| Pension and deferred compensation | $0 | $0 |
| All other | $14,852 | $0 |
| Total | $622,888 | $732,303 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: SPRUCE BIOSCIENCES, INC. DEF 14A filed April 7, 2022, accession 0001140361-22-013615, and prior-year filings. Open the filing on EDGAR.
How this page was built: the SPRUCE BIOSCIENCES, INC. filed document, accession 0001140361-22-013615. Every figure is read from that document and cited to the page and table it appears in. Filed April 7, 2022.
Equity holdings
unvested awards at FY2021 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| Option | 9,078 | — | $1.44 |
| Option | 10,000 | — | $15.24 |
| Option | 50,000 | — | $2.48 |
Per the Outstanding Equity Awards at Fiscal Year-End table in SPRUCE BIOSCIENCES, INC.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
15 Form 4 lines since the FY2021 proxy (filed April 7, 2022)current to 2026-11-21 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-05-21 | Grant or award derivative | — | 1,700 | $0.00 | 1,700 |
| 2025-12-11 | Grant or award derivative | — | 1,499 | — | 1,499 |
| 2025-12-11 | Grant or award derivative | — | 666 | — | 666 |
| 2025-12-11 | Grant or award derivative | — | 400 | — | 400 |
| 2025-12-11 | Disposition to the issuer derivative | — | 387 | — | 0 |
| 2025-12-11 | Disposition to the issuer derivative | — | 1,255 | — | 0 |
| 2025-12-11 | Disposition to the issuer derivative | — | 1,499 | — | 0 |
| 2025-12-11 | Disposition to the issuer derivative | — | 133 | — | 0 |
The 8 most recent of 15 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
SPRUCE BIOSCIENCES’s named executive officers, FY2021
as the company reported each| Named executive officer | Role | FY2021 total |
|---|---|---|
| Richard King | Former Chief Executive Officer | $5,106,007 |
| Samir Gharib | President and Chief Financial Officer | $2,380,295 |
| Rosh Dias | Former Chief Medical Officer | $1,105,614 |
| Michael Grey · this page | Executive Chairman and Former Interim Chief Executive Officer | $732,303 |
Board service
SPRUCE BIOSCIENCES board · FY2023–FY2025| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $70,000 | $0 | $9,940 | $0 | $79,940 |
| FY2024 | $70,000 | — | $19,224 | $0 | $89,224 |
| FY2023 | $70,000 | — | $49,392 | $0 | $119,392 |
Each year as the company reported it in SPRUCE BIOSCIENCES's director compensation table. Totals are the company's own disclosed totals.
How this board is paid
Company policy: SPRUCE BIOSCIENCES pays directors a $40,000 cash retainer. As stated in SPRUCE BIOSCIENCES's FY2025 proxy.
The full SPRUCE BIOSCIENCES compensation record
free company briefThis page is one person within SPRUCE BIOSCIENCES's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are SPRUCE BIOSCIENCES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.